A. Bruce Montgomery

6.8k citations

55 papers · 4.6k indexed · 1 hit paper · h-index 28

Pulmonary and Respiratory Medicine top 0.5%
Epidemiology top 2%
Critical Care and Intensive Care Medicine top 0.5%
Molecular Medicine top 0.5%
Physiology top 5%

Co-authors: Alexandra L. Quittner Kelly Otto Bonnie W. Ramsey Arnold L. Smith Christopher M. Oermann Karen McCoy George Retsch‐Bogart Ronald L. Gibson
Topics: Cystic Fibrosis Research Advances (30 papers)Inhalation and Respiratory Drug Delivery (23 papers)Pneumonia and Respiratory Infections (15 papers)
Cited by: Critical Care and Intensive Care Medicine Molecular Medicine Pulmonary and Respiratory Medicine
Journals: New England Journal of Medicine JAMA American Journal of Respiratory and Critical Care Medicine
Partner nations: United States Australia United Kingdom

In The Last Decade

A. Bruce Montgomery

55 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis

1999 974 citations Bonnie W. Ramsey, Margaret S. Pepe et al. profile →

Peers

Countries citing papers authored by A. Bruce Montgomery

Since Specialization

Citations

This map shows the geographic impact of A. Bruce Montgomery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Bruce Montgomery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Bruce Montgomery more than expected).

Fields of papers citing papers by A. Bruce Montgomery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Bruce Montgomery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Bruce Montgomery. The network helps show where A. Bruce Montgomery may publish in the future.

Co-authorship network of co-authors of A. Bruce Montgomery

This figure shows the co-authorship network connecting the top 25 collaborators of A. Bruce Montgomery. A scholar is included among the top collaborators of A. Bruce Montgomery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Bruce Montgomery. A. Bruce Montgomery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-dose pharmacokinetics and lung function of nebulized niclosamide ethanolamine in sheep 2023 ·Pharmaceutical Research ·Anne Weiss,Robert J. Bischof,Cornelia B. Landersdorfer,Tri‐Hung Nguyen,Andrew Davies,(unknown),Paul Wynne,(unknown),(unknown),A. Bruce Montgomery,Els Meeusen,Michelle P. McIntosh,Morten Otto Alexander Sommer	3
2	Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose–response trial 2023 ·Thorax ·Alex West,Nazia Chaudhuri,Adam Barczyk,Margaret Wilsher,Peter Hopkins,Ian Glaspole,Tamera J. Corte,Martina Šterclová,Antony Veale,Ewa Jassem,Marlies Wijsenbeek,Christopher Grainge,Wojciech Piotrowski,Ganesh Raghu,Michele L. Shaffer,Deepthi Nair,Lisa C. Freeman,Kelly Otto,A. Bruce Montgomery	35
3	A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase 1 Study of Aerosolized Pirfenidone Delivered via the PARI Investigational eFlow Nebulizer in Volunteers and Patients with Idiopathic Pulmonary Fibrosis 2019 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·(unknown),A. Bruce Montgomery,Kelly Otto,(unknown),(unknown),Jason D. Lickliter,Ian Glaspole	30
4	A Randomized Double-Blind Placebo-Controlled Dose-Escalation Phase 1 Study of Aerosolized Amikacin and Fosfomycin Delivered via the PARI Investigational eFlow ^® Inline Nebulizer System in Mechanically Ventilated Patients 2014 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·A. Bruce Montgomery,Shirley Vallance,Tammy Abuan,(unknown),(unknown)	59
5	Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials 2014 ·The Lancet Respiratory Medicine ·Alan F. Barker,Anne E. O’Donnell,Patrick A. Flume,Philip J. Thompson,(unknown),Javier de Gracia,Wim Boersma,Anthony De Soyza,Lixin Shao,Jenny Zhang,(unknown),Sandra A. Lewis,(unknown),A. Bruce Montgomery,Matthew McKevitt,David Gossage,Alexandra L. Quittner,Thomas G. O’Riordan	153
6	Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores 2014 ·Thorax ·Alexandra L. Quittner,Anne E. O’Donnell,Matthias Salathé,Sandra A. Lewis,Xiaoming Li,A. Bruce Montgomery,Thomas G. O’Riordan,Alan F. Barker	121
7	Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB) 2013 ·European Respiratory Journal ·Alan R. Barker,Anne O’Donnell,Philip J. Thompson,Patrick A. Flume,(unknown),Javier de Gracia,Wim Boersma,Eva Polverino,Lixin Shao,Jenny Zhang,(unknown),(unknown),Matt McKevitt,A. Bruce Montgomery,Alexandra L. Quittner,David Gossage,Thomas G. O’Riordan	10
8	Acute Hyperkalemia Associated with Inhalation of a Potent ENaC Antagonist: Phase 1 Trial of GS-9411 2013 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Thomas G. O’Riordan,(unknown),Peter Hodsman,John H. Ansede,Terry Newcomb,Sandra A. Lewis,William D. Flitter,(unknown),Melissa Johnson,A. Bruce Montgomery,David G. Warnock,Richard C. Boucher	45
9	Regulatory Aspects of Phase 3 Endpoints for New Inhaled Antibiotics for Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections 2012 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·A. Bruce Montgomery,Tammy Abuan,(unknown)	9
10	Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection 2011 ·American Journal of Respiratory and Critical Care Medicine ·Bruce C. Trapnell,Susanna A. McColley,Dana G. Kissner,Mark W. Rolfe,Jonathan M. Rosen,Matthew McKevitt,Lisa Moorehead,A. Bruce Montgomery,David E. Geller	103
11	Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI) 2011 ·Journal of Antimicrobial Chemotherapy ·Christopher M. Oermann,Karen McCoy,George Retsch‐Bogart,Ronald L. Gibson,Matt McKevitt,A. Bruce Montgomery	35
12	Inhaled Lidocaine for the Treatment of Asthma: Lack of Efficacy in Two Double-Blind, Randomized, Placebo-Controlled Clinical Studies 2010 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Tammy Abuan,(unknown),A. Bruce Montgomery	11
13	An 18‐month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis 2010 ·Pediatric Pulmonology ·Christopher M. Oermann,George Retsch‐Bogart,Alexandra L. Quittner,Ronald L. Gibson,Karen McCoy,A. Bruce Montgomery,Peter Cooper	147
14	Efficacy of Aztreonam Lysine for Inhalation (AZLI) in patients with cystic fibrosis and drug resistant P. aeruginosa (DRPA) 2009 ·Journal of Cystic Fibrosis ·Karen McCoy,George Retsch‐Bogart,(unknown),Christopher M. Oermann,Matt McKevitt,A. Bruce Montgomery	10
15	Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis 2009 ·CHEST Journal ·George Retsch‐Bogart,Alexandra L. Quittner,Ronald L. Gibson,Christopher M. Oermann,Karen McCoy,A. Bruce Montgomery,Peter Cooper	214
16	Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection 2009 ·CHEST Journal ·Alexandra L. Quittner,Avani C. Modi,Claire Wainwright,Kelly Otto,Jean Kirihara,A. Bruce Montgomery	303
17	Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis 2008 ·American Journal of Respiratory and Critical Care Medicine ·Karen McCoy,Alexandra L. Quittner,Christopher M. Oermann,Ronald L. Gibson,George Retsch‐Bogart,A. Bruce Montgomery	269
18	The Choice of Compressor Effects the Aerosol Parameters and the Delivery of Tobramycin from a Single Model Nebulizer 2000 ·Journal of Aerosol Medicine ·T. A. Standaert,Donald R. VanDevanter,Bonnie W. Ramsey,(unknown),(unknown),D J Gmur,(unknown),(unknown),A. Bruce Montgomery	17
19	A Comparison of Peak Sputum Tobramycin Concentration in Patients With Cystic Fibrosis Using Jet and Ultrasonic Nebulizer Systems 1997 ·CHEST Journal ·Jay D. Eisenberg,Margaret S. Pepe,(unknown),A. Bruce Montgomery,Arnold L. Smith,Bonnie W. Ramsey	101
20	Ineffectiveness of High-dose Methylprednisolone in Preventing Parenchymal Lung Injury and Improving Mortality in Patients with Septic Shock 1988 ·American Review of Respiratory Disease ·John M. Luce,A. Bruce Montgomery,(unknown),Joan Turner,Craig A. Metz,John F. Murray	360

About A. Bruce Montgomery

A. Bruce Montgomery is a scholar working on Critical Care and Intensive Care Medicine, Molecular Medicine and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 4.6k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (30 papers), Inhalation and Respiratory Drug Delivery (23 papers) and Pneumonia and Respiratory Infections (15 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (615 citations), Molecular Medicine (574 citations) and Pulmonary and Respiratory Medicine (3.7k citations). A. Bruce Montgomery has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Alexandra L. Quittner, Kelly Otto, Bonnie W. Ramsey, Arnold L. Smith, Christopher M. Oermann, Karen McCoy, George Retsch‐Bogart, Ronald L. Gibson, Joanne Quan and John F. Murray. Their work appears in journals such as New England Journal of Medicine, JAMA and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact